SGS Poitiers Lab Receives GMP Certification - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SGS Poitiers Lab Receives GMP Certification


SGS Life Science Services announced that its bioanalytical laboratory in Poitiers, France has received GMP certification, following approval from the Agence Nationale de Sécurité du Médicaments et des Produits de Santé (ANSM), the French agency charged with ensuring the quality of drug products. With this GMP certification, the laboratory can provide tests required for final batch release, the company reports in a press statement.

The GMP services will be performed in dedicated suites and controlled access areas of 200 square meters. The facility has been operating under GLP since 1994. With the Life Science Services laboratory in Clichy, France, the company provides services covering GMP activities for small and large molecules.

By bringing GMP to the Poitiers site, the company can offer cell-based assays for testing of biologics, including biosimilars. The company plans to bring bioanalytical capability to the West Coast of North America with a new facility in Carson, Cailf.

Source: SGS

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here